L J Couderc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
L J Couderc has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- E. Catherinot
Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes - INSERM U550, Faculté de Médecine Necker, Paris, France
9 shared publications E. Rivaud
9 shared publications- Patrick Honderlick
Service de Microbiologie, Hôpital Foch, Suresnes, France
6 shared publications C. Tcherakian
5 shared publications- Hélène Salvator
¶University Paris 13, PRES Sorbonne Paris Cité, EA2363, Bobigny, France
5 shared publications L. Zemoura
5 shared publications
Latest Publications
- 1 January 2018
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 35, A115
Fibroélastose Pleuroparenchymateuse (PPFE) après radiothérapie thoracique
- 1 January 2018
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 35, A115
Fibroélastose Pleuroparenchymateuse (PPFE) après radiothérapie thoracique
- 1 January 2018
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 35, A20-A21
Pneumopathies interstitielles non infectieuses post allogreffe de cellules souches hématopoïétiques : série de 40 patients explorés à l’hôpital Foch
- 1 January 2018
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 35, A20-A21
Pneumopathies interstitielles non infectieuses post allogreffe de cellules souches hématopoïétiques : série de 40 patients explorés à l’hôpital Foch
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A61-A62
Bronchectasies modérées et exacerbations répétées chez un patient BPCO : et si c’était une ABPA ? À propos d’une étude cas–témoins sur 32 patients
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A61-A62
Bronchectasies modérées et exacerbations répétées chez un patient BPCO : et si c’était une ABPA ? À propos d’une étude cas–témoins sur 32 patients
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A33
Dilatations des bronches chez les adultes atteints de déficits immunitaires héréditaires humoraux diagnostiqués dans l’enfance
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A33
Dilatations des bronches chez les adultes atteints de déficits immunitaires héréditaires humoraux diagnostiqués dans l’enfance
- 1 January 2015
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 32, A204-A205
Benfluorex et maladies pleurales
- 1 January 2015
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 32, A204-A205
Benfluorex et maladies pleurales
- 1 January 2015
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 32, A47
Cancer broncho-pulmonaire chez le greffé rénal : une étude cas-témoins multicentrique
- 1 January 2015
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 32, A47
Cancer broncho-pulmonaire chez le greffé rénal : une étude cas-témoins multicentrique
- 1 January 2013
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 30, A22
Rôle de l’antigène galactomannane dans le lavage broncho-alvéolaire
- 1 January 2013
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 30, A22
Rôle de l’antigène galactomannane dans le lavage broncho-alvéolaire
- 28 February 2007
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 24 (2) , 145-154
Approche diagnostique d’une pneumopathie chez un malade atteint d’hémopathie maligne
- 28 February 2007
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 24 (2) , 145-154
Approche diagnostique d’une pneumopathie chez un malade atteint d’hémopathie maligne
- 1 February 2007
- Vol. 24 (2) , 145-54
[Management of the pulmonary complications of haematological malignancy].
The high frequency of pulmonary complications of haematological malignancy and the increasing number of patients treated for these disorders make it important that the respiratory physician has a structured diagnostic approach according to: 1 the immune deficiency due to the malignancy and/or the treatment administered; 2 the factors that can modify the risk of infection (anti infection prophylaxis and/or pre-emptive treatment); 3 co-morbidities; 4 extra-pulmonary manifestations. Two main situations can be identified: The patient is aplasic: Initially the pneumonias are predominantly of bacterial origin but may be fungal if the neutropenia is prolonged. The respiratory physician is faced with two problems: 1 the diagnosis of pneumonia; this may be helped by CT scanning; 2 The choice of antibiotics; this will depend on previous investigations. The patient is not aplasic: The lung disease may have many causes, mainly infectious but also drug related, tumoral, haemorrhagic or embolic. The main problem is the correct choice of investigations to establish an aetiological diagnosis. The collection of data according to a pre-established protocol based on simple factors (study of the notes and clinical examination) is one of the key elements for improving the prognosis of these patients whose management should be multidisciplinary following a pre-defined plan.
- 1 February 2007
- Vol. 24 (2) , 145-54
[Management of the pulmonary complications of haematological malignancy].
The high frequency of pulmonary complications of haematological malignancy and the increasing number of patients treated for these disorders make it important that the respiratory physician has a structured diagnostic approach according to: 1 the immune deficiency due to the malignancy and/or the treatment administered; 2 the factors that can modify the risk of infection (anti infection prophylaxis and/or pre-emptive treatment); 3 co-morbidities; 4 extra-pulmonary manifestations. Two main situations can be identified: The patient is aplasic: Initially the pneumonias are predominantly of bacterial origin but may be fungal if the neutropenia is prolonged. The respiratory physician is faced with two problems: 1 the diagnosis of pneumonia; this may be helped by CT scanning; 2 The choice of antibiotics; this will depend on previous investigations. The patient is not aplasic: The lung disease may have many causes, mainly infectious but also drug related, tumoral, haemorrhagic or embolic. The main problem is the correct choice of investigations to establish an aetiological diagnosis. The collection of data according to a pre-established protocol based on simple factors (study of the notes and clinical examination) is one of the key elements for improving the prognosis of these patients whose management should be multidisciplinary following a pre-defined plan.